Anafranil

Anafranil is a brand name of clomipramine, approved by the FDA in the following formulation(s):

ANAFRANIL (clomipramine hydrochloride - capsule; oral)

• 
  Manufacturer: MALLINCKRODT LLC
  
  Approval date: December 29, 1989
  
  Strength(s): 25MG ^[AB], 50MG ^[RLD][AB], 75MG ^[AB]

Has a generic version of Anafranil been approved?

Yes. The following products are equivalent to Anafranil:

clomipramine hydrochloride capsule; oral

• 
  Manufacturer: MYLAN
  
  Approval date: April 30, 1998
  
  Strength(s): 25MG ^[AB], 50MG ^[AB], 75MG ^[AB]


• 
  Manufacturer: SANDOZ
  
  Approval date: March 29, 1996
  
  Strength(s): 25MG ^[AB], 50MG ^[AB], 75MG ^[AB]


• 
  Manufacturer: TARO
  
  Approval date: December 31, 1996
  
  Strength(s): 25MG ^[AB], 50MG ^[AB], 75MG ^[AB]


• 
  Manufacturer: TEVA
  
  Approval date: August 26, 1997
  
  Strength(s): 25MG ^[AB], 50MG ^[AB], 75MG ^[AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Anafranil. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Anafranil.

See also...

• Anafranil Consumer Information (Wolters Kluwer)
• Anafranil Consumer Information (Cerner Multum)
• Anafranil Advanced Consumer Information (Micromedex)
• Anafranil AHFS DI Monographs (ASHP)
• Clomipramine Consumer Information (Wolters Kluwer)
• Clomipramine Consumer Information (Cerner Multum)
• Clomipramine Advanced Consumer Information (Micromedex)
• Clomipramine Hydrochloride AHFS DI Monographs (ASHP)